Minextab

MINimum EXcipient TABlet

MINEXTAB® is an innovative drug delivery system for high dosage form and improving the patient compliance.

      4.2-Minextab 

4-2-Minextab-schema1

This technology is useful for reducing size of tablet.

Immediate release, modified release, bimodale release can be achieved.
MINEXTAB® uses conventional and scalable manufacturing process, well known in the healthcare industries.

Release profile: immediate, modified, bimodale

4-2-minextab-graphique

MINEXTAB® is a valuable tool for high dosages and for improving the compliance.

All selected excipients included in MINEXTAB® innovative drug product technology, are described in the current Pharmacopoeae, an essential key for drug product approval.

Galenix has achieved a number of marketed formulations employing the MINEXTAB® technology; the first product developed with this technology included acetaminophen.


Benefits of MINEXTAB® technology:

4-2-Minextab-video-mini
Click here for the video

  • Enhanced patient acceptabilityAt least 85% of active ingredient included in tablet
  • Tailored drug release profile
  • Excipients described in the current Pharmacopoeia (EP, USP, JP) and GRAS
  • Conventional manufacturing process
  • Reduction of tablet size by at least 50%
  • Preferred drug delivery system for solid dosage form with high dose


 

 

 

 

 

 

 

 

GALENIX INNOVATIONS - Allee des Palanques - 33127 ST JEAN D'ILLAC - FRANCE

Tel: +33 (0)826 39 69 18 - Fax: +33 (0)5 56 68 83 01